ERBB2 and neoplasm: For patients who are lymph node positive, HER2-positive, or have triple-negative breast cancer (TNBC) and a tumor size of >1 cm, adjuvant anthracycline with cyclophosphamide and taxane-based chemotherapy is the backbone of treatment [6].